Kane Biotech signs Canadian distribution agreement with Ontario Medical Supply

Verifying
  • Kane Biotech signed a non-exclusive Canadian distribution agreement with Ontario Medical Supply.
  • OMS will sell two revyve wound products cleared by the U.S. FDA and approved by Health Canada.
  • Ontario Health atHome served more than 680,000 patients and recorded 11.1 million nursing visits in 2024–25.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Kane Biotech signs Canadian distribution agreement with Ontario Medical Supply - CoinPost Terminal